Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Other Non-Current Liabilities (2018 - 2024)

Pharma-Bio Serv's Other Non-Current Liabilities history spans 7 years, with the latest figure at $660903.0 for Q4 2024.

  • For Q4 2024, Other Non-Current Liabilities changed N/A year-over-year to $660903.0; the TTM value through Oct 2024 reached $660903.0, changed N/A, while the annual FY2024 figure was $660903.0, N/A changed from the prior year.
  • Other Non-Current Liabilities reached $660903.0 in Q4 2024 per PBSV's latest filing, down from $1.4 million in the prior quarter.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $1.6 million in Q4 2022 to a low of $17950.0 in Q1 2020.
  • Average Other Non-Current Liabilities over 5 years is $385000.7, with a median of $17950.0 recorded in 2020.
  • Peak YoY movement for Other Non-Current Liabilities: plummeted 96.77% in 2020, then soared 9031.19% in 2022.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $73389.0 in 2020, then plummeted by 75.54% to $17950.0 in 2021, then skyrocketed by 9031.19% to $1.6 million in 2022, then fell by 12.9% to $1.4 million in 2023, then plummeted by 53.7% to $660903.0 in 2024.
  • Per Business Quant, the three most recent readings for PBSV's Other Non-Current Liabilities are $660903.0 (Q4 2024), $1.4 million (Q3 2023), and $1.4 million (Q2 2023).